Status:

UNKNOWN

Inhaled Ibuprofen to Treat COVID-19

Lead Sponsor:

Química Luar SRL

Collaborating Sponsors:

National Council of Scientific and Technical Research, Argentina

Centro de Excelencia en Productos y Procesos Córdoba

Conditions:

Coronavirus Infection

Respiratory Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The study aims to evaluate the reduction in severity and progression of lung injury with inhaled ibuprofen in patients with severe acute respiratory syndrome due to SARS-CoV-2 virus.

Eligibility Criteria

Inclusion

  • Provision of written informed consent by the patient OR by the patient's Legal Representative.
  • Confirmed or suspected SARS-CoV-2 infection;
  • Pneumonia without criteria of severity.
  • With some of the following conditions:
  • Diabetes.
  • Cardiovascular disease.
  • Chronic kidney disease.
  • Chronic obstructive pulmonary disease.
  • Structural diseases of the lung
  • Immunocompromise.
  • Patient who presents negative results by rtPCR for SARS CoV-2, in case of being highly suspicious, the patient may receive it empirically until the results are obtained.
  • No unstable bronchial asthma

Exclusion

  • The doctor considers that participation in the Program is not the best for patients or for any condition that prevents the Program from being followed safely.
  • Patients with a history of unstable bronchial asthma
  • The patient is allergic to ibuprofen or any of the compounds in the preparation.
  • Hypersensitivity to the drug, nasal polyps syndrome, angioedema or bronchospasm against aspirin or other NSAIDs.
  • Pregnant or lactating woman, or positive pregnancy test on a pre-dose exam.
  • Patient who is expected to be transferred to another place other than the place where the Program starts, within 7 days of starting it.

Key Trial Info

Start Date :

May 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2021

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04382768

Start Date

May 1 2020

End Date

January 1 2021

Last Update

June 11 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centro de Excelencia en Productos y Procesos Córdoba

Córdoba, Argentina, 5000